STAMFORD, Conn., Nov. 14, 2026 (GLOBE NEWSWIRE) -- Oban BioPharma today announced that preclinical data for OBT-676, a lead small-molecule candidate for the treatment of obesity and type 2 diabetes, has been selected for a late-breaking presentation at the upcoming Obesity Society's Annual Meeting, Obesity Week®, taking place from November 14–17, 2026 in National Harbor, MD.…
STAMFORD, Conn., Nov. 14, 2026 (GLOBE NEWSWIRE) -- Oban BioPharma today announced that preclinical data for OBT-676, a lead small-molecule candidate for the treatment of obesity and type 2 diabetes, has been selected for a late-breaking presentation at the upcoming Obesity Society's Annual Meeting, Obesity Week®, taking place from November 14–17, 2026 in National Harbor, MD. OBT-676 is a new molecular entity that achieves potent full agonism at the amylin and calcitonin receptors (DACRA) while simultaneously delivering partial agonism across the GLP-1, GIP, and glucagon (Triple-G) pathways. In a 28-day diet-induced obesity (DIO) study in rats, once-daily oral OBT-676 drove rapid, sustained weight loss (up to -17%), including deep visceral fat depletion (up to -42.5%) and hepatic defatting, followed by marked glycemic control with insulin sensitization on a Day 29 oral glucose-tolerance test (oGTT).
NEW YORK, Nov. 14, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Webull Corporation (NASDAQ: BULL) between April 26, 2025 and October 6, 2026, both dates inclusive (the “Class Period”), of the important December 7, 2026 lead plaintiff deadline in the securities class action… ...
NEW YORK, Nov. 14, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of UP Fintech Holding Limited (NASDAQ: TIGR) between April 22, 2024 and June 2, 2026, both dates inclusive (the “Class Period”), of the important December 28, 2026 lead plaintiff deadline in the securities… ...
RADNOR, Pa., Nov. 14, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Aurora Innovation, Inc. (“Aurora Innovation”) (NASDAQ: AUR) on behalf of investors who purchased or acquired Aurora Innovation securities and experienced significant fina...
Eureka Ergonomic's Black Friday & Cyber Monday Sale Is Live: A Bulk Office Furniture Buying Guide, with Buy More, Save More Discounts of up to an Extra 10% ...
